Large-scale testing (Phase 3)Study completedNCT01976312
What this trial is testing
Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Central Retinal Vein Occlusion (CRVO)
Who this might be right for
Central Retinal Vein Occlusion
Novartis Pharmaceuticals 252